CMC Requirements for New Drug Registration in Latin America
ISPE
MAY 9, 2023
In an era when the world is accelerating the development of drugs and targeted medicines using innovative technologies, pharmaceutical companies still face registration hurdles for well-characterized molecules because of redundant or additional local regulatory requirements. Resolution RDC 10/2011. Published 24 March 2011.
52 
Let's personalize your content